Prostate Cancer - Results from #28300

AUA 2011 - Pre-operative urinary prostate cancer gene 3 (PCA3) is predicting pathologically confirmed small volume and insignificant prostate cancer - Session Highlights May 16, 2011

AUA 2011 - Implications of surgical margin status on prostate cancer-specific survival - Session Highlights May 16, 2011

AUA 2011 - Phase 1-2 study of MDV3100 in pre-and post-docetaxel advanced prostate cancer: long-term efficacy results - Session Highlights May 16, 2011

AUA 2011 - Benefit of denosumab therapy in patients with bone metastases from castrate resistant prostate cancer: A number-needed-to-treat (NNT) analysis - Session Highlights May 16, 2011

AUA 2011 - Stromal but not epithelial androgen receptor level is associated with prostate cancer related death - Session Highlights May 16, 2011

AUA 2011 - Neuropeptides promote castration resistant prostate cancer through intracrine androgen biosynthesis - Session Highlights May 16, 2011

AUA 2011 - Androgen independent, tumor-reinitiating cells are selected by androgen deprivation in models of androgen dependent prostate cancer - Session Highlights May 16, 2011

AUA 2011 - Interleukin-6: A potential biomarker of resistance to multitargeted receptor tyrosine kinase inhibitors in castration-resistant prostate cancer - Session Highlights May 16, 2011

AUA 2011 - Andrographolide targets AR pathway in castration-resistant prostate cancer - Session Highlights May 16, 2011

AUA 2011 - Meat and related meat mutagen consumption and risk of advanced prostate cancer - Session Highlights May 16, 2011

AUA 2011 - The natural history of ultrasensitive PSA following radical prostatectomy - Session Highlights May 16, 2011

AUA 2011 - Regional availability of proton beam therapy and variation in treatment for men with low risk prostate cancer in California - Session Highlights May 16, 2011

AUA 2011 - Consistency of tumor position on repeat prostate biopsy in men on active surveillance for prostate cancer-implications for hemiablation - Session Highlights May 16, 2011

AUA 2011 - Smoking and adverse outcomes at radical prostatectomy - Session Highlights May 16, 2011

AUA 2011 - Long term results of immediate versus deferred androgen deprivation in patients with no local treatment for T0-4 N0-2 M0 prostate cancer (EORTC 30891) - Session Highlights May 16, 2011

AUA 2011 - Inhibition of prostate cancer progression by dutasteride and the impact on anxiety, quality of life, and urinary symptoms in men undergoing active surveillance: REDEEM study results - Session Highlights May 16, 2011

AUA 2011 - Do margins matter? The influence of positive surgical margins on prostate cancer-specific mortality - Session Highlights May 16, 2011

AUA 2011 - Association of the number of lymph nodes (LN) removed at radical prostatectomy with all-cause (ACM) and prostate cancer-specific mortality (PCSM) - Session Highlights May 16, 2011

AUA 2011 - RRP as stand-alone therapy for high-risk prostate cancer - Session Highlights May 16, 2011

AUA 2011 - SBUR/SUO: Natural history of prostate cancer and its implications for over- and under-treatment - Session Highlights May 15, 2011

Page 1416 of 1453